> FDA affirms that only a fraction of medical apps would likely face regulatory review, a fresh sign that the agency is unlikely to stifle progress in mobile medicine. Item
> Bioanalytical CRO MedeoLinx has landed business from the 10 top drugmakers, which have sought analytics services to slice and dice genomics and clinical trials data. Report
> Better than Google ($GOOG)? Well, at least when it comes to online searches for rare diseases info, a team from the Technical University of Denmark believes that its FindZebra software trumps the web giant. Article